Radioactive Diagnostic Agent drugs compared
Compare all 8 Radioactive Diagnostic Agent drugs side by side. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.
Full ranking · 8 drugs
- 170/100
locametz
Gallium Ga-68 Gozetotide
- 2New
ammonia n 13
Ammonia N-13
- 3New
amyvid
Florbetapir F-18
- 4New
fludeoxyglucose f18
Fludeoxyglucose F-18
- 5New
gallium ga 68 gozetotide
Gallium Ga-68 Gozetotide
- 6New
glofil-125
Iothalamate Sodium I-125
- 7New
gozellix
Gallium Ga-68 Gozetotide
- 8New
illuccix
Gallium Ga-68 Gozetotide
Frequently asked questions
What is the Radioactive Diagnostic Agent drug class?
Radioactive Diagnostic Agent is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 8 Radioactive Diagnostic Agent products, each independently rated.
Are all Radioactive Diagnostic Agent drugs the same?
No. Radioactive Diagnostic Agent drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
Sources: the Radioactive Diagnostic Agent class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class); how the class works is summarized from Radionuclide Imaging in Cancer Medicine - Holland-Frei Cancer Medicine, NCBI Bookshelf. Ratings are pharmaranks’ independent FDA recall-safety analysis.